Identifying Antimicrobial Metabolites from Bacillus licheniformis
Author Information
Author(s): Soliman Nourhan K., Abbas Ahmad M., El tayeb Wafaa N., Alshahrani Mohammad Y.
Primary Institution: Ain Shams University
Hypothesis
This study aimed at identifying promising antimicrobial metabolites produced by endophytic bacteria from the wild Bassia scoparia plant.
Conclusion
Bacillus licheniformis strain CCASU-B18 was isolated and found to exhibit broad-spectrum antimicrobial activities against various pathogens.
Supporting Evidence
- Bacillus licheniformis strain CCASU-B18 showed broad-spectrum antibacterial activity against multiple drug-resistant pathogens.
- Six main antimicrobial metabolites were identified through genomic and LC-MS analysis.
- The study highlights the potential of endophytes from wild plants in combating antimicrobial resistance.
Takeaway
Scientists found a special bacteria in a plant that can fight germs, which could help us make new medicines.
Methodology
Whole genome sequencing and LC-MS analysis were used to identify antimicrobial metabolites from Bacillus licheniformis.
Limitations
The study recommends further research to optimize culture conditions and test metabolites against a broader range of pathogens.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website